| For: | Gupta T, Jarpula NS. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status. World J Hepatol 2024; 16(3): 353-365 [PMID: 38577535 DOI: 10.4254/wjh.v16.i3.353] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i3/353.htm |
| Number | Citing Articles |
| 1 |
Jiayun Chen, Wenmin Lu, Yanni Lou, Jing Liu, Xiwen Liao, Yunmeng Bai, Guangqing Cheng, Guangzhi Zhu, Ji Feng, Junqi Liu, Zhaoji Liu, Liqun Jia, Jing Zhou, Tao Peng, Guo-Dong Lu, Jigang Wang. Integrating single cell- and spatial- resolved transcriptomics unravels the inter-tumor heterogeneity and immunosuppressive landscape in HBV- and Clonorchis sinensis-associated hepatocellular carcinoma. Molecular Cancer 2026; 25(1) doi: 10.1186/s12943-025-02381-z
|
| 2 |
Konstantina Dimopoulou, Aris Spathis, Christina Papamichail, Aikaterini Athanasiadou, Abraham Pouliakis, Christakis Risilia, Despoina Myoteri, Panayiotis Kokoropoulos, Manousos Konstantoulakis, Ioannis G. Panayiotides, Nikolaos Arkadopoulos, Dina Tiniakos, Periklis G. Foukas. Antigen-specific CD8+CD39+ cytotoxic T cell density in the microenvironment of hepatocellular carcinoma predicts patient survival. British Journal of Cancer 2026; 134(3) doi: 10.1038/s41416-025-03226-8
|
| 3 |
铭阳 唐. Current Research Status and Prospects of Immunotherapy Advances in Hepatocellular Carcinoma. Advances in Clinical Medicine 2025; 15(01) doi: 10.12677/acm.2025.151037
|
| 4 |
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis. Immune Checkpoints and the Immunology of Liver Fibrosis. Livers 2025; 5(1) doi: 10.3390/livers5010005
|
| 5 |
Maria Stella Franzè, Francesca Saffioti, Vasileios K. Mavroeidis. Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2024.212
|
| 6 |
Leonardo Stella, Giuseppe Cabibbo, Ciro Celsa, Roberta Ciccia, Alba Sparacino, Fabio Piscaglia, Francesco Tovoli, Andrea Arleo, Bernardo Stefanini, Massimo Iavarone, Roberta D'Ambrosio, Lucia Cerrito, Maria Pallozzi, Francesco Santopaolo, Fabio Marra, Claudia Campani, Chiara Mazzarelli, Raffaella Viganò, Raffaella Tortora, Alessio Aghemo, Stella De Nicola, Tiziana Pressiani, Lorenza Rimassa, Sherrie Bhoori, Salvatore Corallo, Laura Maiocchi, Andrea Martini, Caterina Soldà, Francesco Paolo Russo, Antonio Gasbarrini, Francesca Romana Ponziani. Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab. Liver International 2025; 45(10) doi: 10.1111/liv.70362
|
| 7 |
Vivek K. Kashyap, Bhuvnesh P. Sharma, Himanshu N. Singh, Sanjay Kumar, Deepak Verma, Deepak Parashar, Murali M. Yallapu, Everardo Cobos, Subhash C. Chauhan. Bioinformatics analysis of TRPV1 expression and its role in hepatocellular carcinoma prognosis. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04744-4
|
| 8 |
Xiang Li, Donghao Yin, Jiahao Geng, Yanyu Xu, Zijing Xu, Xuemeng Yang, Quanwei Li, Zimeng Shang, Zhiyun Yang, Zhong Xu, Jiabo Wang, Enxiang Zhang, Xinhua Song. Machine learning-driven multi-omics analysis identifies a prognostic gene signature associated with programmed cell death and metabolism in hepatocellular carcinoma. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00286-1
|
| 9 |
Xinxin Wang, Zhe Hu, Jiaxuan Ding, Suyongde Zheng, Bangcheng Wei, Yang Zhou, Shuhong Wang. Prognostic Nomogram for Hepatocellular Carcinoma Patients with High Systemic Immune-Inflammation Index: Validation in Surgical and Immunotherapy Cohorts and Exploration of Immune Microenvironment Mechanisms. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S588390
|
| 10 |
Xiao-Wei Wang, Yu-Xing Tang, Fu-Xi Li, Jia-Le Wang, Gao-Peng Yao, Da-Tong Zeng, Yu-Lu Tang, Bang-Teng Chi, Qin-Yan Su, Lin-Qing Huang, Di-Yuan Qin, Gang Chen, Zhen-Bo Feng, Rong-Quan He. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(10): 4244-4263 doi: 10.4251/wjgo.v16.i10.4244
Abstract(521) |
Core Tip(521) |
Full Article(HTML)(2422)
|
Full Article (PDF)-15497K(163)
|
Full Article with Cover (PDF)-15821K(198)
|
Full Article (XML)-170K(108)
|
Audio-2589K(15)
|
Peer-Review Report-181K(107)
|
Answering Reviewers-99K(113)
|
Supplementary Material-666K(102)
|
Times Cited (2)
|
Total Visits (3589)
|
Open
|
| 11 |
Zehao Li, Boqiang Zhong, Qian Zhang, Lin Sun, Xiaoxiao Li, Xiao Hu, Dawei Chen. Multiomics Analysis Identifies Chromosomal Instability‐Associated Immune‐Related Signatures in Hepatocellular Carcinoma by Integrating Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning. Human Mutation 2026; 2026(1) doi: 10.1155/humu/6594696
|
| 12 |
Bangyan L. Stiles. A targeted liver cancer therapy independent of immune checkpoint block. Hepatology 2025; doi: 10.1097/HEP.0000000000001543
|